Fadaltran is a α2-adrenoreceptor antagonist..

FAK inhibitor 5 is the first highly potent, selective irreversible inhibitor of the FAK kinase with IC50 of 0.6 nM.

Falecalcitriol

Famitinib (SHR1020) is a structural analogue of sunitinib, novel and potent multi-targeted RTK inhibitor, including c-Kit, VEGFR2/3, PDGFRβ, FLT-1/3 receptor and c-RET.

Fantofarone is a calcium channel blocker.

Faropenem is an orally active beta-lactam antibiotic with broad-spectrum antibacterial activity against many gram-positive and gram-negative aerobes and anaerobes.

C75 is an inhibitor synthetic fatty-acid synthase (FASN) and inhibits prostate cancer cells PC3 (IC50: 35 μM).

Fasentin is a novel inhibitor of glucose uptake (GLUT) that sensitizes cancer cells to FAS-induced cell death, preferentially inhibits GLUT4 (IC50=68 uM) over GLUT1.

FAS-IN-1 is a potent inhibitor of fatty acid synthase (FAS) wtih IC50 of 10 nM..

FAS-IN-1 tosylate is a potent inhibitor of fatty acid synthase (FAS) extracted from patent WO 2012064642 A1, compound 29; has an IC50 of 10 nM.

Fatostatin ia an inhibitor of sterol regulatory element binding protein (SREBP). It impairs the activation of SREBP-1 and SREBP-2.

FB23-2 is a potent, selective inhibitor of the mRNA N 6-methyladenosine (m 6A) demethylase FTO, directly bind to FTO, inhibits FTO demethylation of m6 A in RNA in vitro with IC50 of 2.6 uM.

FC131 (cyclo(-D-Tyr-Arg-Arg-Nal-Gly-)) is a selective, cyclopentapeptide CXCR4 antagonist with IC50 of 126 nM, exhibits anti-HIV activity in assays using NL4-3 and IIIB strains with EC50 of 21 nM..

FCCP is a very potent uncoupler of oxidative phosphorylation in mitochondria,that disrupts ATP synthesis by transporting protons across cell membranes.

FCPR03 is a novel potent, selective PDE4 inhibitor with IC50 of 60, 31 and 47 nM for PDE4CAT (PDE4 catalytic domain), PDE4B1 and PDE4D7, respectively.

FD-44 (FD44, NCS-1-Ric8a inhibitor FD44) is a potent inhibitor of the NCS-1/Ric8a interaction, interferes with NCS-1/Ric8a binding, and restores normal synapse number and associative learning in a Drosophila FXS model.

FDL-169 is a novel and potent CFTR (Cystic fibrosis transmembrane conductance regulator) corrector being developed by Flatley Discovery Lab for treating cystic fibrosis (CF) patients who carry the F508del mutation

FEBUXOSTAT is an inhibitor xanthine oxidase and xanthine dehydrogenase

Felbamate (Felbatol) is an anticonvulsant drug used in the treatment of epilepsy.

Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker.

FEN1-IN-1 is a potent, selective Flap Endonuclease-1 (FEN1) inhibitor with IC50 of 11 nM.

FEN1-IN-C20 is an N‐hydroxyl urea derivative that specifically inhibits flap endonuclease 1 (FEN1) activity with IC50 of 3 nM.

Fenbendazole (Panacur)

Fenofibric acid is a lipid regulating agent available as delayed release capsules for oral administration.

Fenoldopam(SKF 82526) mesylate is a drug and synthetic benzazepine derivative which acts as a selective D1 receptor partial agonist.

Fenoprofen calcium

Fenoxaprop-P-ethyl is a post-emergent phenoxy herbicide of the aryloxyphenoxy propionate group.

Fenticonazole nitrate

Feretoside, a phenolic compound extracted from the barks of E. ulmoides, is a HSP inducer which act as cytoprotective agent.

Ferulic acid methyl ester (Methyl ferulate) is a derivative of ferulic acid, isolated from Stemona tuberosa, with anti-inflammatory and antioxidant properties. Ferulic acid methyl ester is a cell membrane and brain permeable compound, shows free radical s

Fesoterodine (PF-00695838) is a competitive muscarinic receptor antagonist with muscle relaxant and urinary antispasmodic properties.

Fesoterodine (PF-00695838) is a competitive muscarinic receptor antagonist with muscle relaxant and urinary antispasmodic properties.

Fexinidazole is a new Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping Sickness

FF-10501-01 is a potent, selective and orally available IMPDH inhibitor.

FF-10502 (FF-10502-01) is a pyrimidine nucleoside antimetabolite that shows growth inhibition of pancreatic cancer cell lines with IC50 of 60-330 nM.

FFN-206 is an excellent VMAT2 (vesicular monoamine transporter 2) substrate capable of detecting VMAT2 activity in intact cells using fluorescence microscopy, with subcellular localization to VMAT2-expressing acidic compartments without apparent labeling

FGI-103 is a small-molecule inhibitor of filovirus that exhibits potent antiviral activity against of EBOV (EC90=330 nM, ZEBOV) and MARV (EC50=2.5 uM, MARV-Ci67).

FGI-104 is a small-molecule inhibitor of filovirus that exhibits potent antiviral activity against of EBOV (EC90=330 nM, ZEBOV) and MARV (EC50=2.5 uM, MARV-Ci67).

FH1 (BRD-K4477) is a small molecule, which promotes differentiation of iPS-derived hepatocytes.

Fhit-IN-15 is a potent, competitive, reversible inhibitor of the enzymatic activity of tumor suppressor Fhit with IC50 of 49 nM, shows cytotoxicity in HEK293T cells..

FICZ is a high affinity aryl hydrocarbon receptor (AhR) agonist with Kd of 70 pM.

Fidarestat (SNK860) is a potent aldose reductase inhibitor, improves motor nerve conduction velocity (MNCV) and metabolic abnormalities in sciatic nerve were investigated in acute STZ-induced diabetic rats..

Filaminast (WAY-PDA-641.

Filibuvir (PF-00868554.

Fimasartan(BR-A-657) is a non-peptide angiotensin II receptor antagonist used for the treatment of hypertension and heart failure.

FimH inhibitor 5h is a potent and orally active FimH inhibitor.

Finazine is a high-affinity, brain penetrant sigma-1 and sigma 2 receptor ligand with Ki of 2.6 nM and 46 nM, respectively.

Finerenone (BAY 94-8862) is a third-generation, selective, and orally available nonsteroidal mineralocorticoid receptor (MR) antagonist (IC50=18 nM). Finerenone displays excellent selectivity versus glucocorticoid receptor (GR), androgen receptor (AR), and progesterone receptor (>500-fold). Finerenone has the potential for cardiorenal diseases research, such as type 2 diabetes mellitus and chronic kidney disease.

Firategrast is an orally bioavailable alpha4 beta1/alpha4 beta7 integrin antagonist designed to reduce trafficking of lymphocytes into the central nervous system (CNS).

FIT-039 is a potent, selective CDK9 inhibitor with IC50 of 5.8 uM for CKD9/cyclin T1, suppresses the replication of HSV-1 (IC50=0.69 uM).

FITM is a nove mGlu1 inhibitor. FITM shows high affinity (Ki = 2.5 nM, fig. S2) and selectivity for mGlu1 over mGlu5.

Pioglitazone is a potent and selective PPARγ agonist with high affinity binding to the PPARγ ligand-binding domain with EC50 of 0.93 and 0.99 μM for human and mouse PPARγ, respectively.

FJ 5002 is a potent telomerase inhibitor with IC50 of 2 uM, a close derivative of MKT077.

FKGK18 (FKGK18) is a potent, selective inhibitor of iPLA2 (group VIA Ca2+-independent phospholipase A2) with IC50 of 50 nM.

Flagelin 22 TFA, a fragment of bacterial flagellin, is an effective elicitor in both plants and algae.

Flavoxate Hydrochloride(DW-61 Hydrochloride) is a muscarinic AChR antagonist used in various urinary syndromes and as an antispasmodic.

Fleroxacin (Quinodis)

FLI-06 is a novel potent and selective small molecule intercepting Notch signaling and the early secretory pathway (EC50 ~2.3 μM).

Flibanserin is a novel multifunctional serotonin agonist and antagonist (MSAA) that improves sexual functioning in premenopausal women who suffer from reduced sexual interest and desire.

FLT3-IN-1(SKLB4771) is a novel potent and selective Flt3 inhibitor with IC50 of 10 nM; against FLT3-ITD-expressing MV4-11 cells with IC50 of 6 nM.

Flubendazole is a potent broad spectrum anthelmintic.

Fluconazole

Flucytosine (5-Fluorocytosine, 5-FC, Ancobon) is an antifungal drug with IC50 of 0.12 μg/mL in C.albicans.

Fludarabine (Synonyms: F-ara-A; NSC 118218) is a prodrug converted to free nucleoside 9-β-D-arabinosyl-2-fluoroadenine (F-ara-A). F-ara-A enters cells and accumulates as 5’-triphosphate. Interferes with DNA synthesis and repair.

Fludarabine Phosphate is an analogue of adenosine and deoxyadenosine, which is able to compete with dATP for incorporation into DNA and inhibit DNA synthesis.

Fluensulfone is a new nematicide of the fluoroalkenyl thioether group that has significantly reduced environmental impact with low toxicity to non-target insects and mammals.

Flumatinib is a multi-kinase inhibitor with IC50 Values of 1.2 nM, 307.6 nM and 2662 nM for c-Abl, PDGFRβ and c-Kit respectively.

Flumequine

Flunarizine is a selective calcium entry blocker.

Fluocinolone acetonide (Flucort-N)

Fluocinonide(Vanos)

Fluorescein isothiocyanate(FITC) is a derivative of fluorescein used in wide-ranging applications including flow cytometry.

Fluorescein-5-maleimide is a fluorescent thiol-reactive dye used to conjugate fluorescein to proteins (excitation: 494 nm, emission: 519 nm).

Fluoroclebopride is useful chemical for PET image study.

Fluoxymesterone is an Androgen. The mechanism of action of fluoxymesterone is as an Androgen Receptor Agonist.

Fluspirilene is a non-competitive antagonist of L-type calcium channels with an IC50 of 0.03 μM. Fluspirileneis a long-acting injectable depot antipsychotic drug used for schizophrenia.

Fluticasone furoate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity.

Fluticasone is a synthetic glucocorticoid which is used in some countries to treat nasal symptoms.

Fluticasone propionate (Flonase, Veramyst)

Fluvastatin, Sodium Salt is a synthetic inhibitor of HMGCR (HMG-CoA reductase) (IC50 = 40-100 nM for human liver microsomes) that acts as an anti-hypercholesterolemic compound and as an antioxidant. Fluvastatin also inhibits induction of the LDL receptor

Fluvoxamine maleate is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor.

Fluzoparib (SHR 3162) is a selective poly [ADP-ribose] polymerase 1 (PARP1) and poly [ADP-ribose] polymerase 2 inhibitor (PARP2), being developed by Jiangsu HengRui Medicine, for the treatment of cancer. PARP enzymes play a vital role in repair of DNA dam

FMF-04-159-2 is a covalent CDK14 inhibitor. FMF-04-159-2 inhibits CDK14 and CDK2 with IC50s of 39.6 nM and 256 nM in NanoBRET assay, respectively.

FN075 is a small-molecule inhibitor targeting Escherichia coli amyloid biogenesis and biofilm formation.

FOBISIN 101 is a small molecule 14-3-3 protein-protein interaction inhibitor with IC50 of 9.3 and 16.4 uM for the binding of 14-3-3ζ or 14-3-3γ to PRAS40, respectively.

Fomepizole is a competitive inhibitor of alcohol dehydrogenase, the enzyme that catalyzes the initial steps in the metabolism of ethylene glycol and methanol to their toxic metabolites.

Fondaparinux sodium is a synthetic and specific inhibitor of activated Factor X (Xa).

Acesulfame potassium is an artificial sweetener. Acesulfame potassium (long-term) affects cognitive functions, potentially via altering neuro-metabolic functions in mice.

Acotiamide monohydrochloride trihydrate is an orally active and first-in-class gastroprokinetic agent for the treatment of functional dyspepsia. Acotiamide monohydrochloride trihydrate enhances acetylcholine released by enteric neurons through muscarinic

For the detailed information of AS-2034178,AS 2034178, the solubility of AS-2034178,AS 2034178 in water, the solubility of AS-2034178,AS 2034178 in DMSO, the solubility of AS-2034178,AS 2034178 in PBS buffer, the animal experiment (test) of AS-2034178,AS 2034178, the cell expriment (test) of AS-2034178,AS 2034178, the in vivo, in vitro and clinical trial test of AS-2034178,AS 2034178, the EC50, IC50,and affinity,of AS-2034178,AS 2034178, For the detailed information of AS-2034178,AS 2034178, the solubility of AS-2034178,AS 2034178 in water, the solubility of AS-2034178,AS 2034178 in DMSO, the solubility of AS-2034178,AS 2034178 in PBS buffer, the animal experiment (test) of AS-2034178,AS 2034178, the cell expriment (test) of AS-2034178,AS 2034178, the in vivo, in vitro and clinical trial test of AS-2034178,AS 2034178, the EC50, IC50,and affinity,of AS-2034178,AS 2034178, Please contact DC Chemicals..

For the detailed information of BBS-4, the solubility of BBS-4 in water, the solubility of BBS-4 in DMSO, the solubility of BBS-4 in PBS buffer, the animal experiment (test) of BBS-4, the cell expriment (test) of BBS-4, the in vivo, in vitro and clinical trial test of BBS-4, the EC50, IC50,and affinity,of BBS-4, Please contact DC Chemicals..

For the detailed information of Betamethasone valerate (Betnovate), the solubility of Betamethasone valerate (Betnovate) in water, the solubility of Betamethasone valerate (Betnovate) in DMSO, the solubility of Betamethasone valerate (Betnovate) in PBS buffer, the animal experiment（test） (test) of Betamethasone valerate (Betnovate), the cell expriment (test) of Betamethasone valerate (Betnovate), the in vivo, in vitro and clinical trial test of Betamethasone valerate (Betnovate), the EC50, IC50,and Affinity of Betamethasone valerate (Betnovate),, please contact DC Chemicals..

For the detailed information of BIO-32546, the solubility of BIO-32546 in water, the solubility of BIO-32546 in DMSO, the solubility of BIO-32546 in PBS buffer, the animal experiment (test) of BIO-32546, the cell expriment (test) of BIO-32546, the in vivo, in vitro and clinical trial test of BIO-32546, the EC50, IC50,and affinity,of BIO-32546, For the detailed information of BIO-32546, the solubility of BIO-32546 in water, the solubility of BIO-32546 in DMSO, the solubility of BIO-32546 in PBS buffer, the animal experiment (test) of BIO-32546, the cell expriment (test) of BIO-32546, the in vivo, in vitro and clinical trial test of BIO-32546, the EC50, IC50,and affinity,of BIO-32546, Please contact DC Chemicals..

For the detailed information of Dimesna, the solubility of Dimesna in water, the solubility of Dimesna in DMSO, the solubility of Dimesna in PBS buffer, the animal experiment（test） (test) of Dimesna, the cell expriment (test) of Dimesna, the in vivo, in vitro and clinical trial test of Dimesna, the EC50, IC50,and Affinity of Dimesna,, please contact DC Chemicals..

For the detailed information of DTP3, the solubility of DTP3 in water, the solubility of DTP3 in DMSO, the solubility of DTP3 in PBS buffer, the animal experiment (test) of DTP3, the cell expriment (test) of DTP3, the in vivo, in vitro and clinical trial test of DTP3, the EC50, IC50,and affinity,of DTP3, Please contact DC Chemicals..

For the detailed information of Epothilone F, the solubility of Epothilone F in water, the solubility of Epothilone F in DMSO, the solubility of Epothilone F in PBS buffer, the animal experiment (test) of Epothilone F, the cell expriment (test) of Epothilone F, the in vivo, in vitro and clinical trial test of Epothilone F, the EC50, IC50,and Affinity of Epothilone F, Please contact DC Chemicals..

For the detailed information of IN00076730, the solubility of IN00076730 in water, the solubility of IN00076730 in DMSO, the solubility of IN00076730 in PBS buffer, the animal experiment (test) of IN00076730, the cell expriment (test) of IN00076730, the in vivo, in vitro and clinical trial test of IN00076730, the EC50, IC50,and affinity,of IN00076730, For the detailed information of IN00076730, the solubility of IN00076730 in water, the solubility of IN00076730 in DMSO, the solubility of IN00076730 in PBS buffer, the animal experiment (test) of IN00076730, the cell expriment (test) of IN00076730, the in vivo, in vitro and clinical trial test of IN00076730, the EC50, IC50,and affinity,of IN00076730, Please contact DC Chemicals..

For the detailed information of KF-4317, the solubility of KF-4317 in water, the solubility of KF-4317 in DMSO, the solubility of KF-4317 in PBS buffer, the animal experiment (test) of KF-4317, the cell expriment (test) of KF-4317, the in vivo, in vitro and clinical trial test of KF-4317, the EC50, IC50,and Affinity of KF-4317, Please contact DC Chemicals..

For the detailed information of LHW090-A7, the solubility of LHW090-A7 in water, the solubility of LHW090-A7 in DMSO, the solubility of LHW090-A7 in PBS buffer, the animal experiment (test) of LHW090-A7, the cell expriment (test) of LHW090-A7, the in viv

For the detailed information of Naxagolide, the solubility of Naxagolide in water, the solubility of Naxagolide in DMSO, the solubility of Naxagolide in PBS buffer, the animal experiment (test) of Naxagolide, the cell expriment (test) of Naxagolide, the in vivo, in vitro and clinical trial test of Naxagolide, the EC50, IC50,and Affinity of Naxagolide, Please contact DC Chemicals..

For the detailed information of NI-(S)-BPB-GLY, the solubility of NI-(S)-BPB-GLY in water, the solubility of NI-(S)-BPB-GLY in DMSO, the solubility of NI-(S)-BPB-GLY in PBS buffer, the animal experiment (test) of NI-(S)-BPB-GLY, the cell expriment (test) of NI-(S)-BPB-GLY, the in vivo, in vitro and clinical trial test of NI-(S)-BPB-GLY, the EC50, IC50,and Affinity of NI-(S)-BPB-GLY, Please contact DC Chemicals..

Nitenpyram is a chemical frequently used as an insecticide in agriculture and veterinary medicine. The compound is an insect neurotoxin belonging to the class of neonicotinoids which works by blocking neural signaling of the central nervous system.

For the detailed information of NSC157100, the solubility of NSC157100 in water, the solubility of NSC157100 in DMSO, the solubility of NSC157100 in PBS buffer, the animal experiment (test) of NSC157100, the cell expriment (test) of NSC157100, the in vivo, in vitro and clinical trial test of NSC157100, the EC50, IC50,and Affinity of NSC157100, Please contact DC Chemicals..

For the detailed information of NSC17711, the solubility of NSC17711 in water, the solubility of NSC17711 in DMSO, the solubility of NSC17711 in PBS buffer, the animal experiment (test) of NSC17711, the cell expriment (test) of NSC17711, the in vivo, in vitro and clinical trial test of NSC17711, the EC50, IC50,and Affinity of NSC17711, Please contact DC Chemicals..

For the detailed information of Ospemifene, the solubility of Ospemifene in water, the solubility of Ospemifene in DMSO, the solubility of Ospemifene in PBS buffer, the animal experiment (test) of Ospemifene, the cell expriment (test) of Ospemifene, the in vivo, in vitro and clinical trial test of Ospemifene, the EC50, IC50,and Affinity of Ospemifene, Please contact DC Chemicals..

For the detailed information of PB30239, the solubility of PB30239 in water, the solubility of PB30239 in DMSO, the solubility of PB30239 in PBS buffer, the animal experiment (test) of PB30239, the cell expriment (test) of PB30239, the in vivo, in vitro and clinical trial test of PB30239, the EC50, IC50,and Affinity of PB30239, Please contact DC Chemicals..

For the detailed information of PF-0668759, the solubility of PF-0668759 in water, the solubility of PF-0668759 in DMSO, the solubility of PF-0668759 in PBS buffer, the animal experiment (test) of PF-0668759, the cell expriment (test) of PF-0668759, the

For the detailed information of Phenothrin, the solubility of Phenothrin in water, the solubility of Phenothrin in DMSO, the solubility of Phenothrin in PBS buffer, the animal experiment (test) of Phenothrin, the cell expriment (test) of Phenothrin, the in vivo, in vitro and clinical trial test of Phenothrin, the EC50, IC50,and affinity,of Phenothrin, For the detailed information of Phenothrin, the solubility of Phenothrin in water, the solubility of Phenothrin in DMSO, the solubility of Phenothrin in PBS buffer, the animal experiment (test) of Phenothrin, the cell expriment (test) of Phenothrin, the in vivo, in vitro and clinical trial test of Phenothrin, the EC50, IC50,and affinity,of Phenothrin, Please contact DC Chemicals..

For the detailed information of praeruptorin B, the solubility of praeruptorin B in water, the solubility of praeruptorin B in DMSO, the solubility of praeruptorin B in PBS buffer, the animal experiment（test） (test) of praeruptorin B, the cell expriment (test) of praeruptorin B, the in vivo, in vitro and clinical trial test of praeruptorin B, the EC50, IC50,and Affinity of praeruptorin B,, please contact DC Chemicals..

For the detailed information of PST2286, the solubility of PST2286 in water, the solubility of PST2286 in DMSO, the solubility of PST2286 in PBS buffer, the animal experiment (test) of PST2286, the cell expriment (test) of PST2286, the in vivo, in vitro and clinical trial test of PST2286, the EC50, IC50,and affinity,of PST2286, Please contact DC Chemicals..

For the detailed information of Reboxetine mesylate, the solubility of Reboxetine mesylate in water, the solubility of Reboxetine mesylate in DMSO, the solubility of Reboxetine mesylate in PBS buffer, the animal experiment（test） (test) of Reboxetine mesylate, the cell expriment (test) of Reboxetine mesylate, the in vivo, in vitro and clinical trial test of Reboxetine mesylate, the EC50, IC50,and Affinity of Reboxetine mesylate,, please contact DC Chemicals..

For the detailed information of RO 15-3890, the solubility of RO 15-3890 in water, the solubility of RO 15-3890 in DMSO, the solubility of RO 15-3890 in PBS buffer, the animal experiment (test) of RO 15-3890, the cell expriment (test) of RO 15-3890, the in vivo, in vitro and clinical trial test of RO 15-3890, the EC50, IC50,and Affinity of RO 15-3890, Please contact DC Chemicals..

A small molecule tumor translocation inhibitor that inhibits the prostate cancer cell transcriptional program, in part by inhibition of the demethylase KDM4C (IC50=30 uM).

For the detailed information of SKP2-C25, the solubility of SKP2-C25 in water, the solubility of SKP2-C25 in DMSO, the solubility of SKP2-C25 in PBS buffer, the animal experiment (test) of SKP2-C25, the cell expriment (test) of SKP2-C25, the in vivo, in vitro and clinical trial test of SKP2-C25, the EC50, IC50,and affinity,of SKP2-C25, For the detailed information of SKP2-C25, the solubility of SKP2-C25 in water, the solubility of SKP2-C25 in DMSO, the solubility of SKP2-C25 in PBS buffer, the animal experiment (test) of SKP2-C25, the cell expriment (test) of SKP2-C25, the in vivo, in vitro and clinical trial test of SKP2-C25, the EC50, IC50,and affinity,of SKP2-C25, Please contact DC Chemicals..

HIV-1 integrase inhibitor 8 is a HIV-1 integrase inhibitor, compound 8[1].

For the detailed information of SR03168, the solubility of SR03168 in water, the solubility of SR03168 in DMSO, the solubility of SR03168 in PBS buffer, the animal experiment (test) of SR03168, the cell expriment (test) of SR03168, the in vivo, in vitro and clinical trial test of SR03168, the EC50, IC50,and Affinity of SR03168, Please contact DC Chemicals..

For the detailed information of SR03298A, the solubility of SR03298A in water, the solubility of SR03298A in DMSO, the solubility of SR03298A in PBS buffer, the animal experiment (test) of SR03298A, the cell expriment (test) of SR03298A, the in vivo, in vitro and clinical trial test of SR03298A, the EC50, IC50,and Affinity of SR03298A, Please contact DC Chemicals..

For the detailed information of SR10067, the solubility of SR10067 in water, the solubility of SR10067 in DMSO, the solubility of SR10067 in PBS buffer, the animal experiment (test) of SR10067, the cell expriment (test) of SR10067, the in vivo, in vitro and clinical trial test of SR10067, the EC50, IC50,and affinity,of SR10067, For the detailed information of SR10067, the solubility of SR10067 in water, the solubility of SR10067 in DMSO, the solubility of SR10067 in PBS buffer, the animal experiment (test) of SR10067, the cell expriment (test) of SR10067, the in vivo, in vitro and clinical trial test of SR10067, the EC50, IC50,and affinity,of SR10067, Please contact DC Chemicals..

For the detailed information of Sulfamethazine, the solubility of Sulfamethazine in water, the solubility of Sulfamethazine in DMSO, the solubility of Sulfamethazine in PBS buffer, the animal experiment（test） (test) of Sulfamethazine, the cell expriment (test) of Sulfamethazine, the in vivo, in vitro and clinical trial test of Sulfamethazine, the EC50, IC50,and Affinity of Sulfamethazine,, please contact DC Chemicals..

For the detailed information of Tenovin-2, the solubility of Tenovin-2 in water, the solubility of Tenovin-2 in DMSO, the solubility of Tenovin-2 in PBS buffer, the animal experiment (test) of Tenovin-2, the cell expriment (test) of Tenovin-2, the in vivo, in vitro and clinical trial test of Tenovin-2, the EC50, IC50,and affinity,of Tenovin-2, Please contact DC Chemicals..

For the detailed information of Tenovin-5, the solubility of Tenovin-5 in water, the solubility of Tenovin-5 in DMSO, the solubility of Tenovin-5 in PBS buffer, the animal experiment (test) of Tenovin-5, the cell expriment (test) of Tenovin-5, the in vivo, in vitro and clinical trial test of Tenovin-5, the EC50, IC50,and affinity,of Tenovin-5, Please contact DC Chemicals..

For the detailed information of Tradipitant(VLY-686), the solubility of Tradipitant(VLY-686) in water, the solubility of Tradipitant(VLY-686) in DMSO, the solubility of Tradipitant(VLY-686) in PBS buffer, the animal experiment (test) of Tradipitant(VLY-686), the cell expriment (test) of Tradipitant(VLY-686), the in vivo, in vitro and clinical trial test of Tradipitant(VLY-686), the EC50, IC50,and affinity,of Tradipitant(VLY-686), For the detailed information of Tradipitant(VLY-686), the solubility of Tradipitant(VLY-686) in water, the solubility of Tradipitant(VLY-686) in DMSO, the solubility of Tradipitant(VLY-686) in PBS buffer, the animal experiment (test) of Tradipitant(VLY-686), the cell expriment (test) of Tradipitant(VLY-686), the in vivo, in vitro and clinical trial test of Tradipitant(VLY-686), the EC50, IC50,and affinity,of Tradipitant(VLY-686), Please contact DC Chemicals..

For the detailed information of Zucapsaicin, the solubility of Zucapsaicin in water, the solubility of Zucapsaicin in DMSO, the solubility of Zucapsaicin in PBS buffer, the animal experiment (test) of Zucapsaicin, the cell expriment (test) of Zucapsaicin, the in vivo, in vitro and clinical trial test of Zucapsaicin, the EC50, IC50,and affinity,of Zucapsaicin, For the detailed information of Zucapsaicin, the solubility of Zucapsaicin in water, the solubility of Zucapsaicin in DMSO, the solubility of Zucapsaicin in PBS buffer, the animal experiment (test) of Zucapsaicin, the cell expriment (test) of Zucapsaicin, the in vivo, in vitro and clinical trial test of Zucapsaicin, the EC50, IC50,and affinity,of Zucapsaicin, Please contact DC Chemicals..

Formestane(CGP-32349; 4-OHA) is a selective, type I, steroidal aromatase inhibitor used in the treatment of estrogen-receptor positive breast cancer.

Forskolin is a ubiquitous activator of eukaryotic adenylyl cyclase (AC).

Forsythoside B is a phenylethanoid glycoside isolated from the leaves of Lamiophlomis rotata Kudo, a Chinese folk medicinal plant for treating inflammatory diseases and promoting blood circulation.

Fosdagrocorat (PF 04171327) is an orally available, potential dissociated agonist of the glucocorticoid receptor (GR) for the treatment of rheumatoid arthritis, the phosphate ester prodrug of PF-00251802 (dagrocorat)..

Foslinanib (TRX-818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation.

Fosmidomycin sodium salt is a phosphonic acid antibiotic and a antimalarial drug, which is active against both Gram-negative and Gram-positive bacteria.

Fosravuconazole is a prodrug of ravuconazole, with antifungal activity.

Fostamatinib (R788) is a prodrug of the active metabolite R406, which is a potent, ATP-competitive inhibitor of Syk kinase with Ki/IC50 of 30/41 nM.

Fosteabine is an oral and prodrug analogue of cytarabine which is resistant to deoxycytidine deaminase.

FPH1 (BRD-6125) is a small molecule, which promotes expansion of iPS-derived hepatocytes.

FQI1 is a small-molecule inhibitor of transcription factor LSF with IC50 of 2.1 uM.

FQI2 is a small-molecule inhibitor of transcription factor LSF with IC50 of 0.71 uM.

FR 900098 is a derivative of fosmidomycin that inhibits DOXP reductoisomerase, demonstrates antimalarial activity with IC50 of 170, 170, and 90 nM for HB3, A2, and Dd2 P. falciparum strains, respectively..

FR194738 is a squalene epoxidase inhibitor. FR194738 inhibits squalene epoxidase activity in HepG2 cell homogenates with an IC50 of 9.8 nM.

FR58P1a is a mitochondrial metabolism-affecting compound that uncouples OXPHOS through a protonophoric mechanism, selectively inhibits migration in triple-negative breast cancer cells via Sirt1/AMPK/β1-integrin pathway.

FR-901464 is a potent antitumor natural product that binds to the splicing factor 3b (SF3b) complex and inhibits pre-mRNA splicing, inhibits cell cycle progression at G1 and G2/M phases..

Framycetin sulphate

FRAX486 is a selective inhibitor of group I PAKs with IC50s of 8.25/39.5, /55.3 nM for PAK1/PAK2/PAK3 respectivelt; less potent for PAK4(IC50=779 nM).

Fraxin is a coumarin glycoside that has been found in Fraxinus and has anti-inflammatory activity.

Fraxinellone is a selective blocker of voltage-dependent Ca2+ channel, which possesses antimicrobial, anti-inflammatory, neuroprotective and vasorelaxing activities.

Frentizole, an FDA-approved immunosuppressive drug, is a novel inhibitor of the Aβ-ABAD interaction.

Frovatriptan Succinate is the succinate salt form of frovatriptan, a synthetic triptan with serotonin (5-HT) receptor agonist activity especially for the 5-HT1B/1D receptors.

FSC 231 (FSC231) is the first, cell-permeable small-molecule inhibitor of PICK1 PDZ domain with Kd of 10.1 uM.

FT-001 is a novel potent, orally acitve inhibitor of BET bromodomain with IC50 of 0.1 uM for BRD4 BD1.

FT113 is a potent and orally active fatty acid synthase (FASN) inhibitor, with an IC50 of 213 nM for full-length recombinant human FASN enzyme.

FT895 (FT-895) is a potent and selective inhibitor of HDAC11 with IC50 of 3 nM, displays no significant activity against HDAC1-10 (IC50>5 uM).

FTBMT is a novel selective GPR52 agonist of GPR52, increases intracellular cAMP levels in CHO cells expressing human, mouse, or rat GPR52, with pEC50 of 7.03, 6.85, and 6.87M, respectively.

FtsZ inhibitor C109 (Compound 10126109) is a broad spectrum antibacterial compound that inhibits the cell division protein FtsZ, inhibits the FtsZ GTPase activity with IC50 of 8.2 uM.

Fuchsine base (monohydrochloride) is a magenta dye, which is certified for use for acid-fast staining with carbol-fuchsin.

Fudosteine

Fulacimstat(BAY 1142524) is a small molecule chymase inhibitor.

Fulvestrant is an estrogen receptor (ER) antagonist with IC50 of 0.094 nM.

Fumagillin is a selective and potent irreversible inhibitor of Methionine aminopeptidase 2 (MetAP2), used as an antibiotic to treat microsporidiosis.

Fumalic acid (Ferulic acid)

Fumosorinone is a novel potent, selective protein tyrosine phosphatase SHP2 inhibitor with IC50 of 6.31 uM.

Furosemide (Lasix) is a loop diuretic inhibitor of Na+/2Cl-/K+ (NKCC) cotransporter of which used in the treatment of congestive heart failure and edema.

Fusidate Sodium is a sodium salt form of fusidic acid, a bacteriostatic antibiotic derived from the fungus Fusidium coccineum and used as a topical medication to treat skin infections.

FV-100 (Valnivudine, CF-1743) is a potent, selective, bicyclic nucleoside analogue inhibitor of varicella zoster virus (VZV) with EC50 of subnanomolar range in vitro..

FzM1.8 is a small molecule, allosteric agonist of the Frizzled receptor Fzd4 with pEC50 of 6.4, potentiates β-catenin pathway in the absence of any WNT ligand.

G 0507 is a novel inhibitor of the bacterial LolCDE ABC transporter, binds to LolCDE and stimulates its ATPase activity.

G 573 is a potent and selective, allosteric inhibitor of MEK with Ki of 0.3 nM.

G0775 is a Synethetic analogs of arylomycins.

G10 (STING Agonist 1) is a novel human-specific STING agonist.

G3-C12 (TFA) is a galectin-3 binding peptide, with high affinity (Kd) of 88 nM, but shows no affinity for other galectin family members or to other lectins.

G-5555 is a potent and selective PAK1 inhibitor (Ki=3.7 nM).

G6PD activator AG1 (AG1) is a specific, small molecule that increases the activity of the wild-type, Canton mutant (R459L, EC50=3 uM) and several other common G6PD mutants; displays no effect on the dimerization or activity of several other NAD- or NADP+-dependent dimeric or tetrameric enzymes, including 6PGD, GAPDH, ALDH2, and ALDH3A1; attenuates ROS-induced pericardial edema in a G6PD-dependent manner in zebrafish, reduces hemolysis of human erythrocytes

G907 is a potent, selective small-molecule antagonist of ATP-binding cassette (ABC) transporter MsbA with IC50 of 18 nM.

G9a inhibitor E72 (E-72) is a potent inhibitor of histone H3K9 methyltransferases G9a and G9a-like protein (GLP) with Kd of 136 nM and 164 nM, shows selectivity over the related H3K9 methyltransferase Suv39H2.

Gabexate Mesylate is a Factor X inhibitor.

Gadodiamide is a gadolinium-based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. Target: OthersGadodiamide(Omniscan) is a gadolinium-based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. Gadodiamide is a contrast medium for cranial and spinal magnetic resonance imaging (MRI) and for general MRI of the body after intravenous administration. The product provides contrast enhancement and facilitates visualisation of abnormal structures or lesions in various parts of the body including the central nervous system (CNS). A recent review takes the question of toxicity caused by loss of gadolinium from the complex. "The challenge for nephrologists includes (a) evidence of transmetallation, such as gadolinium deposits in bone, increased urinary zinc excretion, iron-transferrin dissociation or 'spurious hypocalcemia' in exposed people"。

GAK inhibitor 49 is a potent, selective, ATP-competitive inhibitor of cyclin G-associated kinase (GAK, cell IC50=56 nM) with favourable NAK family selectivity (AAK1, STK16, BMP2K).

Galactose 1-phosphate is an intermediate in the galactose metabolism and nucleotide sugars.

Galactose 1-phosphate Potassium salt is is an intermediate in the galactose metabolism and nucleotide sugars

Galvestine-1 is a small molecule MGDG (monogalactosyldiacylglycerol) synthase inhibitor with IC50 of 10 uM by competing with diacylglycerol binding.

Gamitrinib TPP is a GA mitochondrial matrix inhibitor.

gamma-secretase modulator 3 is a gamma-secretase modulator.

Ganaplacide (KAF156, GNF-156) is a novel antimalarial clinical candidate that shows blood schizonticidal activity with IC50 of 6-17.4 nM against P falciparum drug-sensitive and drug-resistant strains.

Ganciclovir

Ganirelix is a man-made form of a protein that reduces the amount of certain hormones in the body, including estrogen.

GANT 61(NSC 136476) is a small molecule inhibitor of Gli1 and Gli2.

GAPDS is a small molecule that targets the glycolytic enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH).

Garcinol (Camboginol) is a potent, natural inhibitor of histone acetyltransferases (HATs) p300 (IC50=7 uM) and PCAF (IC50=5 uM) both in vitro and in vivo.

Gardiquimod trifluoroacetate is a specific TLR7 agonist which can also inhibit HIV-1 reverse transcriptase.

GB1107 (GB-1107, GB 1107) is a potent, selective, orally active inhibitor of Galectin-3 (Gal-3) with Kd of 37 nM (human Galectin-3).

GB-83 is a selective, reversible PAR2 (Protease-activated receptor 2) antagonist with IC50 of 2 uM.

Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma.

GBT-440(Voxelotor) is a novel small molecule hemoglobin modifier which increases hemoglobin oxygen affinity.

GCN2-IN-1 is a potent general control nonderepressible 2 kinase (GCN2) inhibitor with IC50s of <0.3 μM in the enzyme and cell assay.

GDC-0032 is a potent, next-generation β isoform-sparing PI3K inhibitor targeting PI3Kα/δ/γ with IC50 of 0.29 nM/0.12 nM/0.97nM, >10 fold selective over PI3Kβ.

GDC-0068 is a highly selective pan-Akt inhibitor targeting Akt1, Akt2 and Akt3 with IC50 of 5 nM, 18 nM and 8 nM, respectively.

GDC-0152 is a potent inhibitor of IAPs; binds to the XIAP BIR3 domain, the BIR domain of ML-IAP, and the BIR3 domains of cIAP1 and cIAP2 with K(i) values of 28, 14, 17, and 43 nM, respectively.

GDC-0349 is a potent and selective ATP-competitive inhibitor of mTOR with Ki of 3.8 nM; >700-fold selectivity over PI3Kα and other 266 kinases.

GDC046 is a potent lead analog with good kinase selectivity, physicochemical properties, and pharmacokinetic profile.

GDC-0623 is a potent, ATP-uncompetitive inhibitors of MEK1(Ki=0.13 nM, +ATP).

GDC-0927 (SRN-927, RG-6047) is a potent, orally bioavailable, selective estrogen receptor degrader (SERD) for treatment of metastatic hormone receptor-positive/HER2-negative breast cancer..

GDC-0927 (SRN-927, RG-6047) is a potent, orally bioavailable, selective estrogen receptor degrader (SERD) for treatment of metastatic hormone receptor-positive/HER2-negative breast cancer..

GDC-0994 is a potent, orally available ERK1/2 inhibitor with IC50 of 1.1 nM and 0.3 nM, respectively. Phase 1.